To transfer or not to transfer: the dilemma of mosaic embryos - a narrative review.

Genetic counselling Human embryonic mosaicism Next-generation sequencing Preimplantation genetic testing Reproductive outcome

Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 06 06 2023
revised: 19 10 2023
accepted: 30 10 2023
medline: 27 2 2024
pubmed: 27 2 2024
entrez: 26 2 2024
Statut: ppublish

Résumé

A frequent finding after preimplantation genetic diagnostic testing for aneuploidies using next-generation sequencing is an embryo that is putatively mosaic. The prevalence of this outcome remains unclear and varies with technical and external factors. Mosaic embryos can be classified by the percentage of cells affected, type of chromosome involvement (whole or segmental), number of affected chromosomes or affected cell type (inner mass cell, trophectoderm or both). The origin of mosaicism seems to be intrinsic as a post-zygotic mitotic error, but some external factors can play a role. As experience has increased with the transfer of mosaic embryos, clinical practice has gradually become more flexible in recent years. Nevertheless, clinical results show lower implantation, pregnancy and clinical pregnancy rates and higher miscarriage rates with mosaic embryo transfer when compared with the transfer of euploid embryos. Prenatal diagnosis is highly recommended after the transfer of mosaic embryos. This narrative review is intended to serve as reference material for practitioners in reproductive medicine who must manage a mosaic embryo result after preimplantation genetic testing for aneuploidies.

Identifiants

pubmed: 38408811
pii: S1472-6483(23)00763-0
doi: 10.1016/j.rbmo.2023.103664
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103664

Informations de copyright

Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Elkin Muñoz (E)

Reproductive Medicine, IVIRMA Vigo, Vigo, Spain; Department of Obstetrics and Gynecology, University of Cauca, Popayan, Colombia.

Fernando Bronet (F)

IVF Laboratory, IVIRMA Madrid, Madrid, Spain.

Belen Lledo (B)

Instituto Bernabeu, Alicante, Spain.

Gabriela Palacios-Verdú (G)

Unit of Genomic Medicine, Department of Obstetrics, Gynecology and Reproductive Medicine, Institut Universitari Quirón Dexeus, Barcelona, Spain.

Lorena Martinez-Rocca (L)

Research Department, IVIRMA Vigo, Vigo, Spain.

Signe Altmäe (S)

Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Granada, Spain; Instituto de Investigación Biosanitaria ibs, Granada, Granada, Spain; Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Josep Pla (J)

Reproductive Genetics Unit, IVIRMA Global, Barcelona, Spain. Electronic address: Josep.pla@ivirma.com.

Classifications MeSH